Claus Elsborg Olesen
Oprichter bij INITIATOR PHARMA A/S
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Martin Roelsgaard Jakobsen | M | - |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 5 jaar |
Ulf Simonsen | M | 61 |
University of Aarhus
| 15 jaar |
Henrik Kristian Moltke | M | 66 | 8 jaar | |
Gunilla Anders Ekström | M | 66 | 2 jaar | |
Peter Holm | M | 50 | 8 jaar | |
Annette Colin Lövgren | F | 59 | 3 jaar | |
Mikael Søndergaard Thomsen | M | 56 | 8 jaar | |
Gunnar Magnus Modee Persson | M | 64 | 8 jaar | |
Christian Schetter | M | 60 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 5 jaar |
Torgeir Vaage | M | 60 | 8 jaar | |
Sten Verland | M | 67 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
Richard Bethell | M | 61 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
Jonathan Leslie Tobin | M | 42 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 5 jaar |
Allan Wehnert | M | - | 4 jaar | |
Natalie Sacks | M | 59 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | 4 jaar |
Regina Hodits | M | 53 |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
Morten Graugaard Døssing | M | - |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Mathias Vinther | M | - |
University of Aarhus
| 8 jaar |
Dan Peters | M | 63 | - | |
Tanja Groth | M | - |
University of Aarhus
| 7 jaar |
Henrik Scheel | M | - |
University of Aarhus
| 5 jaar |
Johansen Jesper | M | - |
University of Aarhus
| 5 jaar |
Henrik Demant | M | 52 |
University of Aarhus
| 1 jaar |
Sven Vermeulen | M | - |
University of Aarhus
| - |
Jakob Bardram | M | 56 |
University of Aarhus
| 2 jaar |
Christian Sorensen | M | 44 |
University of Aarhus
| 4 jaar |
Allan Larsen | M | - |
University of Aarhus
| 3 jaar |
Christian Jølck | M | - |
University of Aarhus
| 2 jaar |
Jacob Frandsen | M | - |
University of Aarhus
| 5 jaar |
Anders Skov | M | 45 |
University of Aarhus
| 3 jaar |
Dinara Kazybekovna Alimzhanova | F | 39 |
University of Aarhus
| 1 jaar |
Sara Fevre Kindberg | M | - |
University of Aarhus
| 3 jaar |
Fabian Söffge | M | - |
University of Aarhus
| 1 jaar |
René Rømer | M | - |
University of Aarhus
| 1 jaar |
Casper Lerche | M | - |
University of Aarhus
| 4 jaar |
Anders Weihrauch | M | - |
University of Aarhus
| 5 jaar |
Anne Gammelgaard Kaptain | F | 44 |
University of Aarhus
| 3 jaar |
Jacob Jensen | M | - |
University of Aarhus
| 4 jaar |
Søren Kovsted | M | - |
University of Aarhus
| 3 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Denemarken | 39 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Claus Elsborg Olesen
- Persoonlijk netwerk